Olsalazine Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01250 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | myelodysplastic syndrome | KG + DL |
| 2 | hypotrichosis simplex of the scalp | KG + DL |
| 3 | congenital hypotrichosis milia | KG + DL |
| 4 | alopecia | KG + DL |
| 5 | diffuse alopecia areata | KG + DL |
| 6 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 7 | unclassified myelodysplastic syndrome | KG + DL |
| 8 | refractory cytopenia of childhood | KG + DL |
| 9 | aregenerative anemia | KG + DL |
| 10 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 11 | pulmonary hypertension | KG + DL |
| 12 | osteoarthritis susceptibility | KG + DL |
| 13 | rheumatoid arthritis | KG + DL |
| 14 | sclerosing cholangitis | KG + DL |
| 15 | gout | KG + DL |
| 16 | kyphoscoliotic heart disease | KG + DL |
| 17 | osteoarthritis | KG + DL |
| 18 | spondyloarthropathy | KG + DL |
| 19 | exostosis | KG + DL |
| 20 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 21 | brachydactyly-syndactyly syndrome | KG + DL |
| 22 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 23 | WHIM syndrome | KG + DL |
| 24 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 25 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 26 | brachyolmia | KG + DL |
| 27 | juvenile idiopathic arthritis | KG + DL |
| 28 | juvenile arthritis due to defect in LACC1 | KG + DL |
| 29 | tendinitis | KG + DL |
| 30 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 31 | myosclerosis | KG + DL |
| 32 | diabetic nephropathy | KG + DL |
| 33 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 34 | arthropathy | KG + DL |
| 35 | idiopathic granulomatous myositis | KG + DL |
| 36 | myositis fibrosa | KG + DL |
| 37 | fibromyalgia | KG + DL |
| 38 | headache disorder | KG + DL |
| 39 | refractory hematologic cancer | KG + DL |
| 40 | exostoses, multiple, | KG + DL |
| 41 | inclusion body myositis | KG + DL |
| 42 | peripheral vascular disease | KG + DL |
| 43 | juvenile chronic polyarthritis | KG + DL |
| 44 | rheumatoid nodulosis | KG + DL |
| 45 | trigeminal autonomic cephalalgia | KG + DL |
| 46 | pseudoachondroplasia | KG + DL |
| 47 | idiopathic pulmonary arterial hypertension | KG + DL |
| 48 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 49 | pulmonary arterial hypertension | KG + DL |
| 50 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.